Another example is the activation of the PI3K–AKT pathway, one of the most frequently dysregulated signaling pathways in human cancers, via the stimulation of growth factor receptor tyrosine kinases, such as the human epidermal growth factor receptor 2 (HER2) and the IR.114. Here, ERBB2 is linked to cancer.